Medicare GLP-1 Bridge in 2027: extended to December 31
The whole program on one page: Medicare GLP-1 Bridge program.
By John Samaras, price analyst · Prices checked Nov 16, 2026
CMS has extended the Medicare GLP-1 Bridge through December 31, 2027, because the BALANCE Model will not launch in Medicare in 2027. Eligible Part D members keep a $50 copay for Wegovy, Foundayo or the Zepbound KwikPen prescribed for weight management.
What it costs without insurance
If Medicare won't cover it for weight loss
Eden$99 a monthIncludes medication, provider review and shippingCheck price →
Collective$59 a month, drug priceLowest price on our chartCheck price →
Who this affects
People with Medicare Part D who are prescribed one of these drugs to reduce excess weight and who meet CMS's BMI rules. People with type 2 diabetes, moderate to severe sleep apnea or MASH with liver scarring get GLP-1s through their Part D plan instead, and CMS says they cannot use the Bridge.
When it starts
The Bridge began on July 1, 2026. Its second year runs from January 1, 2027 to December 31, 2027.
If you lose coverage: cash now
Two cash programs to check.
No insurance needed.
Prices checked Nov 16, 2026.
- Eden$99 a monthIncludes medication, provider review and shippingcompounded semaglutidecompounded tirzepatide $129 a monthCheck price →Eden's GLP-1 page, then an online assessment
- Check price →
- Compounded semaglutide and tirzepatide prices, from $59 a month
- Find your GLP-1 program in four questions
What the CMS Bridge notice says
The Medicare GLP-1 Bridge will be extended through December 31, 2027
- Only the Zepbound KwikPen is in the Bridge. The single-dose vials and single-dose pens are not.
- In 2026 a GLP-1 fill through Part D that year made a member ineligible. CMS says it has not yet set the lookback period it will use in 2027.
- Coupons and discount programs cannot be applied to Bridge claims, and the $50 does not count toward your Part D out-of-pocket costs.
- The $50 stays the same in every phase of the Part D benefit, and the low-income subsidy does not apply to it.
- A prescriber starts it with a prior authorization request to the Bridge's central processor, which CMS names as Humana.
Sources:
- CMS, Medicare GLP-1 Bridge: information for Part D plans, dated August 6, 2026, read November 15, 2026.
What to do before January 1
- Run the Bridge checker to see whether your BMI and conditions meet CMS's criteria.
- If you filled a GLP-1 through Part D in 2026, watch for CMS's 2027 lookback rule before you count on the Bridge.
- If you do not qualify, compare the cash routes on this page.
Medicare GLP-1 Bridge checker. What each GLP-1 costs on Medicare. Medicare's 2027 negotiated price for Ozempic and Wegovy.
What cash costs today
Compounded semaglutide and tirzepatide are pharmacy-made versions that are not Wegovy, Ozempic, Zepbound or Mounjaro.
Compounded prices are the monthly drug price at the lowest-priced program. Any membership is listed on that program's own page.
| Cash route | Monthly price | Checked |
|---|---|---|
| Compounded semaglutide | From $59 | November 16, 2026 |
| Compounded tirzepatide | From $69 | November 16, 2026 |
| Wegovy pill from NovoCare | From $149 at the 1.5mg starter dose | November 16, 2026 |
| Zepbound vial from LillyDirect | From $299 at 2.5mg | November 16, 2026 |
Buying cash in late November? GLP-1 Black Friday and Cyber Monday offers shows each program's 30-day low and high.
Frequently asked questions
Does the Medicare GLP-1 Bridge continue in 2027?
Which drugs does the Bridge cover in 2027?
Can I use a coupon with the Medicare GLP-1 Bridge?
Cash does not go through your plan and does not count toward its deductible. Federal plan GLP-1 changes for 2027. GLP-1 coverage by payer.